Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joan Walker
Gynecologic Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California Medical Center at Irvine-Orange Campus
Orange, California, United States
- Colorado Gynecologic Oncology Group
Aurora, Colorado, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Greater Baltimore Medical Center
Baltimore, Maryland, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Cooper Hospital University Medical Center
Camden, New Jersey, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- Cleveland Clinic Cancer Center/fairview Hospital
Cleveland, Ohio, United States
- Lake University Ireland Cancer Center
Mentor, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Cancer Care Associates-Midtown
Tulsa, Oklahoma, United States
- Cancer Care Associates-Yale
Tulsa, Oklahoma, United States
- Gynecologic Oncology Group
Philadelphia, Pennsylvania, United States
- Women and Infants Hospital
Providence, Rhode Island, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2004
- Primary completion
- 31 May 2011
- Completion
- —
- Last update posted
- 22 Jul 2019
- Registered enrollment
- 40
- Registry id
- NCT00085358
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.